| nr |
titel |
auteur |
tijdschrift |
jaar |
jaarg. |
afl. |
pagina('s) |
type |
| 1 |
Accelerating progress from advanced to early breast Cancer
|
Rugo, H.
|
|
|
56 |
S1 |
p. S4
|
artikel
|
| 2 |
Accelerating progress from advanced to early breast cancer for TNBC
|
Curigliano, G.
|
|
|
56 |
S1 |
p. S10
|
artikel
|
| 3 |
Accelerating progress from advanced to early breast cancer (SERDS, PI3Kinhibitors, other novel agents)
|
Cescon, D.
|
|
|
56 |
S1 |
p. S5
|
artikel
|
| 4 |
Accelerating progress to innovation for patients: trial design and risk stratification
|
Regan, M.
|
|
|
56 |
S1 |
p. S2-S3
|
artikel
|
| 5 |
A cost-effectiveness analysis of trastuzumab in Taiwanese patients with stage II-III HER2-positive breast cancer and axillary node metastasis
|
Chou, W.
|
|
|
56 |
S1 |
p. S59-S60
|
artikel
|
| 6 |
Adherence to follow-up recommendation guidelines in long term breast cancer survivors, a SURBCAN cohort analysis using administrative databases
|
Santiá, P.
|
|
|
56 |
S1 |
p. S80-S81
|
artikel
|
| 7 |
Adiposity and risk of breast cancer in Chinese women
|
Kartsonaki, C.
|
|
|
56 |
S1 |
p. S39
|
artikel
|
| 8 |
Adjuvant decision making in the era of limited nodal information
|
Giordano, S.
|
|
|
56 |
S1 |
p. S8
|
artikel
|
| 9 |
Adjuvant endocrine therapy for pre- and postmenopausal women
|
Winer, E.
|
|
|
56 |
S1 |
p. S4-S5
|
artikel
|
| 10 |
A multi-functional portable system for diagnosing breast cancer from ex-vivo biopsy tissues
|
Pal, U.M.
|
|
|
56 |
S1 |
p. S86
|
artikel
|
| 11 |
Analysis of exhaled volatile organic compounds: a new frontier in breast cancer screening and surveillance
|
Allard-Coutu, A.
|
|
|
56 |
S1 |
p. S32
|
artikel
|
| 12 |
Analysis of normal tissue complication probability-based radiobiological models: a systematic review of literatures
|
Rahman, M.
|
|
|
56 |
S1 |
p. S29-S30
|
artikel
|
| 13 |
Analysis of primary endocrine therapy in breast cancer patients over 70 years from a single unit in South Africa: analysis of those that choose no surgery first. Highlighting COVID-19 sensitive issues
|
Benn, C.
|
|
|
56 |
S1 |
p. S54
|
artikel
|
| 14 |
Angiosome theory findings using new protocol of CT-angiography improves outcomes in DIEP-flap reconstruction surgery in breast cancer patients
|
Pesotsky, R.
|
|
|
56 |
S1 |
p. S69
|
artikel
|
| 15 |
An ultra low cost vacuum assisted core needle biopsy technique for breast lumps: a pilot study in a resource limited setting
|
Yadav, S.K.
|
|
|
56 |
S1 |
p. S32-S33
|
artikel
|
| 16 |
Application of conventional ultrasonography combined with contrast-enhanced ultrasonography in the lymph nodes and evaluation of the efficacy of neoadjuvant chemotherapy in breast cancer patients
|
Jin, S.
|
|
|
56 |
S1 |
p. S49
|
artikel
|
| 17 |
Appropriateness of handheld Doppler in identification of chest wall perforator for partial breast reconstruction
|
Gupta, N.
|
|
|
56 |
S1 |
p. S70
|
artikel
|
| 18 |
A randomized, double-blind, single-dose study (LAVENDER) to assess the safety, tolerability, and immunogenicity of ABP 980 and pertuzumab combined in a single infusion in healthy subjects
|
Hanes, V.
|
|
|
56 |
S1 |
p. S50
|
artikel
|
| 19 |
Are clinical and molecular features similar in inflammatory breast cancer and non-inflammatory breast cancer?
|
Aissaoui, D.
|
|
|
56 |
S1 |
p. S42
|
artikel
|
| 20 |
Assesment of endocrine sensitivity in primary breast cancer through RS Score and changes in the proliferation index KI67
|
Gasol Cudos, A.
|
|
|
56 |
S1 |
p. S52-S53
|
artikel
|
| 21 |
Assessing the Impact of the COVID-19 outbreak on the oncological practice regarding metastatic breast cancer patients treated with CDK4/6 inhibitors
|
Fouda, M.
|
|
|
56 |
S1 |
p. S86-S87
|
artikel
|
| 22 |
Assessment and reimbursement of gene expression tests in breast cancer in Europe – a comparative policy analysis
|
Plaud, M.-G.
|
|
|
56 |
S1 |
p. S33
|
artikel
|
| 23 |
Assessment of pathological complete response using vacuum assisted biopsy in breast cancer patients who have clinical and radiological complete response after neoadjuvant chemotherapy
|
Khare, S.
|
|
|
56 |
S1 |
p. S54
|
artikel
|
| 24 |
Autologous breast reconstruction with free flaps in patients with oligometastatic breast cancer: when to proceed and when not?
|
Sjokvist, O.
|
|
|
56 |
S1 |
p. S72-S73
|
artikel
|
| 25 |
Awareness and attitudes regarding breast cancer and breast self-examination among female university students: an exploration
|
Katpattil, S.
|
|
|
56 |
S1 |
p. S88
|
artikel
|
| 26 |
Axillary reverse mapping in the prevention of lymphoedema: a systematic review of randomized trials
|
Co, M.
|
|
|
56 |
S1 |
p. S67-S68
|
artikel
|
| 27 |
Axillary surgery in node-positive breast cancer
|
Weber, W.
|
|
|
56 |
S1 |
p. S7
|
artikel
|
| 28 |
Biology of breast cancer after in vitro fertilization (IVF)
|
Izquierdo, M.
|
|
|
56 |
S1 |
p. S24
|
artikel
|
| 29 |
Breast and axillary downstaging after neoadjuvant chemotherapy in breast cancer: surgical technique
|
D’Alonzo, M.
|
|
|
56 |
S1 |
p. S51
|
artikel
|
| 30 |
Breast cancer after in vitro fecundation (IVF): can ovary stimulation and follicular response affect prognostic factors?
|
Izquierdo, M.
|
|
|
56 |
S1 |
p. S60
|
artikel
|
| 31 |
Breast cancer recurrence and survival: what, when and where, a 17-years retrospective cohort
|
Ehsani, A.
|
|
|
56 |
S1 |
p. S32
|
artikel
|
| 32 |
Breast cancer surgery in COVID19 outbreak: the role of therapeutic mammoplasty
|
Sfakianakis, E.
|
|
|
56 |
S1 |
p. S87
|
artikel
|
| 33 |
Breast cancer surveillance in women with PTEN Hamartoma Tumour Syndrome (PHTS)
|
Hoxhaj, A.
|
|
|
56 |
S1 |
p. S38
|
artikel
|
| 34 |
Breast reconstruction and radiation therapy: consensus statements of the Italian association of radiotherapy and clinical oncology (AIRO) breast cancer group
|
Meattini, I.
|
|
|
56 |
S1 |
p. S47
|
artikel
|
| 35 |
Breast screening in BRCA1/2 carriers leads to earlier detection and superior therapy of breast cancers
|
Shraga, S.
|
|
|
56 |
S1 |
p. S35
|
artikel
|
| 36 |
Breast surgery after neoadjuvant treatment
|
Heil, J.
|
|
|
56 |
S1 |
p. S8-S9
|
artikel
|
| 37 |
Breast surgery – where do we go?
|
Gnant, M.
|
|
|
56 |
S1 |
p. S2
|
artikel
|
| 38 |
Bringing diarrhea under CONTROL: dose escalation reduces neratinib-associated diarrhea and improves tolerability in HER2-positive early-stage breast cancer
|
Ruiz-Borrego, M.
|
|
|
56 |
S1 |
p. S18-S19
|
artikel
|
| 39 |
Caloric restriction, physical and creative activities against breast cancer: our pilot study
|
Mondino, A.
|
|
|
56 |
S1 |
p. S84
|
artikel
|
| 40 |
Can we prevent brain metastases?
|
Lin, N.
|
|
|
56 |
S1 |
p. S4
|
artikel
|
| 41 |
Clinical and pathological response to neoadjuvant chemotherapy (NCT) in patients with triple negative breast cancer (TNBC)
|
Krivorotko, P.
|
|
|
56 |
S1 |
p. S52
|
artikel
|
| 42 |
Clinical response and pathological evidence of treating metastatic breast cancer with immunotherapy using stimulated natural dendritic cell pulsed with neoantigen peptides
|
Chatamra, K.
|
|
|
56 |
S1 |
p. S42-S43
|
artikel
|
| 43 |
Clinical significance of discordances in sentinel lymph node reactivity between radioisotope and indocyanine green fluorescence in cN0 breast cancer patients
|
Jimbo, K.
|
|
|
56 |
S1 |
p. S68
|
artikel
|
| 44 |
Clinicopathological and molecular subtypes of early breast cancer in young women in Sudan
|
Siddig, S.
|
|
|
56 |
S1 |
p. S31-S32
|
artikel
|
| 45 |
Clinicopathological characteristics and recurrence patterns among young and very young breast cancer patients in Middle East
|
Omar, A.M.A.
|
|
|
56 |
S1 |
p. S66
|
artikel
|
| 46 |
Comparing MammaPrint and BluePrint results between core needle biopsy and surgical resection breast cancer specimens
|
Kleijn, M.
|
|
|
56 |
S1 |
p. S61-S62
|
artikel
|
| 47 |
Comparing the temporal changes of cosmetic, QoL and patient satisfaction achieved with breast reconstruction and contralateral symmetrisation techniques. (ClinicalTrials.gov: NCT04356235)
|
Újhelyi, M.
|
|
|
56 |
S1 |
p. S70
|
artikel
|
| 48 |
Comparisons of efficacy and safety of nanoparticle albumin-bound paclitaxel and docetaxel neoadjuvant regimens for treating breast cancer: a retrospective real-world study conducted in China
|
Wang, J.
|
|
|
56 |
S1 |
p. S49
|
artikel
|
| 49 |
Conservatives mastectomies and immediate direct to implant breast reconstruction during COVID-19 pandemic: the strategy of the Breast Center Villa Tiberia Hospital
|
Varvaras, D.
|
|
|
56 |
S1 |
p. S77
|
artikel
|
| 50 |
Contents
|
|
|
|
56 |
S1 |
p. iv-v
|
artikel
|
| 51 |
Continued efficacy of neratinib in patients with HER2-positive (HER2+) early-stage breast cancer: final overall survival (OS) analysis from the randomized phase 3 ExteNET trial
|
Martin, M.
|
|
|
56 |
S1 |
p. S19
|
artikel
|
| 52 |
Correlation of breast imaging and pathological subtype of young breast cancer under 35 years old
|
Rakchob, T.
|
|
|
56 |
S1 |
p. S83-S84
|
artikel
|
| 53 |
De-escalation of early breast cancer therapy: Umberto Veronesi’s legacy
|
Cardoso, F.
|
|
|
56 |
S1 |
p. S1
|
artikel
|
| 54 |
Differences of breast tumour localization and size between supine and prone breast MRI for a surgery perspective
|
Civan Kus, C.
|
|
|
56 |
S1 |
p. S40
|
artikel
|
| 55 |
Do residual radionuclides following the Chernobyl accident lead to a distinct subtype of breast cancer?
|
Randhawa, S.
|
|
|
56 |
S1 |
p. S86
|
artikel
|
| 56 |
Dosimetric impact due to volumetric changes of the breast during whole breast irradiation
|
Park, K.R.
|
|
|
56 |
S1 |
p. S46
|
artikel
|
| 57 |
Ductal carcinoma in situ (DCIS) and breast cancer-specific and all-cause mortality among postmenopausal women in the Women’s Health Initiative
|
Pan, K.
|
|
|
56 |
S1 |
p. S72
|
artikel
|
| 58 |
Dynamics of circulating tumor DNA during postoperative radiotherapy for triple-negative breast cancer in patients undergoing neoadjuvant chemotherapy and breast surgery
|
Kim, H.
|
|
|
56 |
S1 |
p. S48
|
artikel
|
| 59 |
Early Breast Cancer Recurrence Score: comparison between Endopredict and Magee Equations in a real-world general hospital
|
Betancor-Fernandez, I.
|
|
|
56 |
S1 |
p. S25
|
artikel
|
| 60 |
E-cadherin expression in triple-negative invasive ductal breast carcinoma
|
Volos, L.
|
|
|
56 |
S1 |
p. S27-S28
|
artikel
|
| 61 |
Editorial Board
|
|
|
|
56 |
S1 |
p. ii-iii
|
artikel
|
| 62 |
Effectivness of breast-conserving treatment for minimal residual tumors after neoadjuvant breast cancer therapy
|
Pesotsky, R.
|
|
|
56 |
S1 |
p. S61
|
artikel
|
| 63 |
Effect of accreditation best practice systems on time to treatment delays: three-year review of a South African internationally accredited site
|
Benn, C.
|
|
|
56 |
S1 |
p. S58-S59
|
artikel
|
| 64 |
Effects of IORT and EBRT methods on local recurrence control in breast cancer patients using Weibull regression model
|
Nafissi, N.
|
|
|
56 |
S1 |
p. S43
|
artikel
|
| 65 |
Efficacy and safety of neoadjuvant therapy for HER2-positive early breast cancer: a network meta-analysis
|
Zhang, J.
|
|
|
56 |
S1 |
p. S49-S50
|
artikel
|
| 66 |
Efficacy and safety of neoadjuvant therapy for Triple-Negative Breast Cancer (TNBC): a Bayesian network meta-analysis
|
Yu, Y.
|
|
|
56 |
S1 |
p. S50
|
artikel
|
| 67 |
Efficacy of fulvestrant in hormone refractory metastatic breast cancer (mBC): a Canadian province experience
|
Andrahennadi, S.
|
|
|
56 |
S1 |
p. S40-S41
|
artikel
|
| 68 |
Emotional implications of women in the gene panel for hereditary cancer
|
Silva-Fernandes, I.J.d.L.
|
|
|
56 |
S1 |
p. S36-S37
|
artikel
|
| 69 |
Epidemiological and clinical characteristics of breast cancer in the southern of Tunisia: about 1067 cases
|
Ben Kridis, W.
|
|
|
56 |
S1 |
p. S40
|
artikel
|
| 70 |
Evaluation of an end of treatment summary in patients with early breast cancer: quality improvement project
|
Nsiah, K.
|
|
|
56 |
S1 |
p. S78-S79
|
artikel
|
| 71 |
Evaluation of incidental implantation of tumor cells after diagnostic needle biopsy in breast cancer patients
|
Maseki, H.
|
|
|
56 |
S1 |
p. S61
|
artikel
|
| 72 |
Evaluation of sentinel lymph node by sonography
|
Hashimoto, T.
|
|
|
56 |
S1 |
p. S34
|
artikel
|
| 73 |
Evaluation of the effect of axillary radiotherapy dose and the development of lymphodema in breast cancer patients
|
Elemary, O.A.
|
|
|
56 |
S1 |
p. S48
|
artikel
|
| 74 |
Evaluation of the efficacy of Trastuzumab in patients with HER2 positive small (pT1mi/a) breast cancers. A multicenter retrospective study on 100 patients
|
Villasco, A.
|
|
|
56 |
S1 |
p. S17-S18
|
artikel
|
| 75 |
Evaluation of the impact of the COVID-19 pandemic on the practice of axillary node dissection
|
Harris, G.A.
|
|
|
56 |
S1 |
p. S73
|
artikel
|
| 76 |
Evolution of adjuvant therapies across the time and the future of cooperative academic clinical research groups
|
Cameron, D.
|
|
|
56 |
S1 |
p. S1
|
artikel
|
| 77 |
Exploring the effects of mastectomy on the sexual health and marital relationship of adult married women at a tertiary care hospital in Karachi, Pakistan
|
Karim, K.
|
|
|
56 |
S1 |
p. S24
|
artikel
|
| 78 |
Expression of RANK-c in ER-/HER2+ breast cancer cells affect aggressiveness through altering the NF-κB equilibrium
|
Sirinian, C.
|
|
|
56 |
S1 |
p. S27
|
artikel
|
| 79 |
Extended adjuvant treatment of patients with HER2+ early breast cancer with neratinib: a multi-centric, prospective, non-interventional study (NIS) in Germany and Austria (ELEANOR)
|
Bartsch, R.
|
|
|
56 |
S1 |
p. S18
|
artikel
|
| 80 |
Factors affecting sentinel lymph node metastasis in patients with breast cancer undergoing sentinel lymph node biopsy before or after systemic therapy
|
Sağdıç, M.F.
|
|
|
56 |
S1 |
p. S67
|
artikel
|
| 81 |
Factors associated with breast cancer screening awareness and participation among West Java Indonesian
|
Azhar, Y.
|
|
|
56 |
S1 |
p. S34
|
artikel
|
| 82 |
Fertility preservation
|
Pagani, O.
|
|
|
56 |
S1 |
p. S12
|
artikel
|
| 83 |
Frequency and spectrum of mutations in the BRCA1, BRCA2, PALB2, P53, PTEN, CHEK2, CDH1 genes in women from 3 cities of Colombia
|
Mejia, A.
|
|
|
56 |
S1 |
p. S88
|
artikel
|
| 84 |
Genetic testing in patients with triple negative or hereditary breast Cancer
|
Garber, J.
|
|
|
56 |
S1 |
p. S6
|
artikel
|
| 85 |
Genomic changes with therapy and detection of molecular recurrence
|
Turner, N.
|
|
|
56 |
S1 |
p. S5
|
artikel
|
| 86 |
Genomic tests for selecting therapy in adjuvant treatment of ER+ breast cancer (BC)
|
Piccart, M.
|
|
|
56 |
S1 |
p. S5-S6
|
artikel
|
| 87 |
Global challenges in breast cancer detection and treatment
|
Barrios, C.H.
|
|
|
56 |
S1 |
p. S3
|
artikel
|
| 88 |
HER2 heterogeneity
|
Prat, A.
|
|
|
56 |
S1 |
p. S4
|
artikel
|
| 89 |
Her-2 positive and TNBC patients receiving neoadjuvant chemotherapy are associated with a high pathological complete response rate – results from real-world outcomes in a multidisciplinary setting
|
Rapoport, B.L.
|
|
|
56 |
S1 |
p. S50-S51
|
artikel
|
| 90 |
Hospital vs community screening for breast cancer
|
Pydisetty, G.
|
|
|
56 |
S1 |
p. S59
|
artikel
|
| 91 |
Hypofractionated radiation therapy after radical mastectomy: predictive factors of acute skin toxicity
|
Ben Amor, R.
|
|
|
56 |
S1 |
p. S43-S44
|
artikel
|
| 92 |
Immunohistochemistry pattern for suppressor tumor and DNA repair genes as screening tool for hereditary breast cancer tracking
|
Picanço de Albuquerque, C.G.
|
|
|
56 |
S1 |
p. S28
|
artikel
|
| 93 |
Immuno-oncology treatment in early stage TNBC
|
Loi, S.
|
|
|
56 |
S1 |
p. S10
|
artikel
|
| 94 |
Impact of endocrine therapy on quality of life in early stage breast cancer patients: prospective patient reported outcomes from the international registry INSPIRE
|
Esgueva, A.
|
|
|
56 |
S1 |
p. S81-S82
|
artikel
|
| 95 |
Impact of irradiation of the internal mammary lymph nodes on heart and lung doses
|
Aissaoui, D.
|
|
|
56 |
S1 |
p. S46-S47
|
artikel
|
| 96 |
Impact of the COVID-19 outbreak on the level of distress in patients with breast cancer
|
Budisavljevic, A.
|
|
|
56 |
S1 |
p. S85
|
artikel
|
| 97 |
Impact of treatment choices based on cancer biology for neoadjuvant breast cancer patients at a multidisciplinary unit in Johannesburg, South Africa
|
Benn, C.
|
|
|
56 |
S1 |
p. S57
|
artikel
|
| 98 |
Implementation of a pathology-supported genetic testing framework for return of research results to family members of deceased breast cancer patients with somatic TP53 variants
|
Moremi, K.E.
|
|
|
56 |
S1 |
p. S64-S65
|
artikel
|
| 99 |
Index
|
|
|
|
56 |
S1 |
p. S91-S96
|
artikel
|
| 100 |
Integrating CDK 4-6 in the treatment of patients with early breast cancer
|
Loibl, S.
|
|
|
56 |
S1 |
p. S6-S7
|
artikel
|
| 101 |
Intrinsic tumor subtype and diagnostic performance of conventional breast imaging technique for the detection of unifocal breast cancer
|
Stanciu Pop, C.
|
|
|
56 |
S1 |
p. S39
|
artikel
|
| 102 |
Ipsilateral breast cancer recurrence: characteristics, treatment, and long-term oncological results at a high volume center
|
Gentile, D.
|
|
|
56 |
S1 |
p. S24-S25
|
artikel
|
| 103 |
Is lobular breast cancer different and should it be treated differently?
|
Gradishar, W.
|
|
|
56 |
S1 |
p. S5
|
artikel
|
| 104 |
Is metaplastic breast cancer more aggressive than “classic” triple-negative ductal carcinoma? Recent prognostic and therapeutic consideration
|
Girardi, A.
|
|
|
56 |
S1 |
p. S85-S86
|
artikel
|
| 105 |
Is number of sentinel nodes enougth after neoadjuvant chemotherapy?
|
Aragón, S.
|
|
|
56 |
S1 |
p. S74-S75
|
artikel
|
| 106 |
Late toxicity of breast cancer treatment and bone health
|
Ejlertsen, B.
|
|
|
56 |
S1 |
p. S12
|
artikel
|
| 107 |
Lifestyle and sexual health
|
Vaz Luis, I.
|
|
|
56 |
S1 |
p. S12
|
artikel
|
| 108 |
Limited indication for neoadjuvant chemotherapy for patients with specific morphological and clinical factors on the basis of individualized exclusion criteria
|
Śniadecki, M.
|
|
|
56 |
S1 |
p. S56-S57
|
artikel
|
| 109 |
Line of therapy adjustment in a patient with advanced triple-negative breast cancer (TNBC) by using personalized ctDNA test for treatment response monitoring
|
Azzi, G.
|
|
|
56 |
S1 |
p. S85
|
artikel
|
| 110 |
Locally advanced breast cancer
|
Aebi, S.
|
|
|
56 |
S1 |
p. S15
|
artikel
|
| 111 |
Long-term trastuzumab treatment in HER2 positive metastatic breast cancer
|
Calamac, M.
|
|
|
56 |
S1 |
p. S82-S83
|
artikel
|
| 112 |
Luteolin suppresses androgen receptor-positive triple-negative breast cancer cell proliferation and metastasis by epigenetic regulation of MMP9 expression via AKT/mTOR signaling pathway
|
Lin, J.
|
|
|
56 |
S1 |
p. S25
|
artikel
|
| 113 |
Lymphoid environment in Luminal A subtype invasive ductal breast carcinoma
|
Volos, L.
|
|
|
56 |
S1 |
p. S27
|
artikel
|
| 114 |
MammaPrint, BluePrint, and full-genome data linked with clinical data to evaluate new gene EXpression profiles (FLEX): a real-world dataset and investigator-initiated protocols in ESBC
|
Crozier, J.A.
|
|
|
56 |
S1 |
p. S62
|
artikel
|
| 115 |
MammaPrint risk score distribution in South African breast cancer patients with the pathogenic BRCA2 c.7934delG founder variant: towards application of genomic medicine at the point-of-care
|
Mampunye, I.
|
|
|
56 |
S1 |
p. S31
|
artikel
|
| 116 |
Management of breast cancer in elderly patients
|
Aapro, M.
|
|
|
56 |
S1 |
p. S14-S15
|
artikel
|
| 117 |
Management of breast cancer in men
|
Cardoso, F.
|
|
|
56 |
S1 |
p. S15
|
artikel
|
| 118 |
Management of patients with residual microcalcifications and false-negative results after stereotactic vacuum – assisted biopsy of mammographic suspicious microcalcifications
|
Georgiou, E.
|
|
|
56 |
S1 |
p. S72
|
artikel
|
| 119 |
Margins and outcomes in breast conserving surgery after neoadjuvant chemotherapy treated with whole breast radiation
|
Lee, J.-H.
|
|
|
56 |
S1 |
p. S53
|
artikel
|
| 120 |
Marked reduction in the risk of dementia in patients with breast cancer: a nationwide population-based cohort study
|
Yoon, C.I.
|
|
|
56 |
S1 |
p. S37
|
artikel
|
| 121 |
Metabolic activity of breast cancer cells in primary tumor models in vitro
|
Herheliuk, T.
|
|
|
56 |
S1 |
p. S83
|
artikel
|
| 122 |
Metaplastic breast cancer, an urgent need for novel therapies
|
Ashoor, A.
|
|
|
56 |
S1 |
p. S42
|
artikel
|
| 123 |
Methylation signatures with diagnostic value in breast cancer via automated machine learning
|
Panagopoulou, M.
|
|
|
56 |
S1 |
p. S38
|
artikel
|
| 124 |
Microcalcifications after neoadjuvant chemotherapy for breast cancer in women achieving pathologic complete response of the invasive disease: do they matter?
|
Gagliardi, T.J.
|
|
|
56 |
S1 |
p. S56
|
artikel
|
| 125 |
Monoallelic MUTYH mutations and hereditary breast cancer - results of an epidemiologic study in Brazil
|
Sant’Ana, R.O.
|
|
|
56 |
S1 |
p. S35-S36
|
artikel
|
| 126 |
Multimorbidity patterns among long-term breast cancer survivors: a Spanish population-based study
|
Jansana, A.
|
|
|
56 |
S1 |
p. S79-S80
|
artikel
|
| 127 |
Musculoskeletal pain and health-related quality of life among breast cancer patients
|
Sha, A.
|
|
|
56 |
S1 |
p. S88-S89
|
artikel
|
| 128 |
Neoadjuvant and adjuvant treatment for triple negative breast cancer
|
Carey, L.
|
|
|
56 |
S1 |
p. S9-S10
|
artikel
|
| 129 |
Neoadjuvant and adjuvant treatment of patients with HER2-positive early breast cancer
|
Harbeck, N.
|
|
|
56 |
S1 |
p. S3-S4
|
artikel
|
| 130 |
Neoadjuvant approach in patients with early breast cancer: evaluation of the breast cancer patient (patient assessment, staging, planning)
|
Rubio, I.T.
|
|
|
56 |
S1 |
p. S12-S13
|
artikel
|
| 131 |
Neoadjuvant chemotherapy. How to work together – the coordination of the multidisciplinary breast team: a logistical challenge
|
Rutgers, E.
|
|
|
56 |
S1 |
p. S14
|
artikel
|
| 132 |
Neo-adjuvant chemotherapy in luminal, node positive breast cancer: characteristics, treatment, and oncological outcomes. A single center’s experience
|
Barbieri, E.
|
|
|
56 |
S1 |
p. S54-S55
|
artikel
|
| 133 |
Neoadjuvant endocrine therapy
|
Johnston, S.
|
|
|
56 |
S1 |
p. S5
|
artikel
|
| 134 |
Neoadjuvant niraparib in patients with HER2-negative, BRCA-mutated resectable breast cancer
|
Spring, L.M.
|
|
|
56 |
S1 |
p. S55-S56
|
artikel
|
| 135 |
Neratinib as extended adjuvant therapy in patients with HER2-positive/HR-positive early breast cancer: German HTA-driven analyses from the ExteNET study
|
Lüftner, D.
|
|
|
56 |
S1 |
p. S17
|
artikel
|
| 136 |
Neutrophil-lymphocyte ratio and nodal pathologic complete response in node positive breast cancer patients undergoing neoadjuvant chemotherapy
|
Gasparri, M.L.
|
|
|
56 |
S1 |
p. S66
|
artikel
|
| 137 |
Oligometastatic disease - optimal treatment for long-term survival
|
Cortés, J.
|
|
|
56 |
S1 |
p. S15-S16
|
artikel
|
| 138 |
Omission of radiation therapy after breast conserving surgery in older early breast cancer among Sudanese patients
|
Siddig, S.
|
|
|
56 |
S1 |
p. S30
|
artikel
|
| 139 |
Omitting axillary lymph node dissection in breast cancer patients with metastatic sentinel node after neoadjuvant chemotherapy
|
Kuru, B.
|
|
|
56 |
S1 |
p. S76-S77
|
artikel
|
| 140 |
Omitting surgical staging of the axilla
|
King, T.
|
|
|
56 |
S1 |
p. S7
|
artikel
|
| 141 |
Oncophone20 study: patients perception of telemedicine during follow up visits
|
Surace, A.
|
|
|
56 |
S1 |
p. S80
|
artikel
|
| 142 |
One size fits all? Novel pulse biopsy platform offers improved needle control, high tissue yield and multiple needle options – pre-clinical results
|
Paepke, S.
|
|
|
56 |
S1 |
p. S51-S52
|
artikel
|
| 143 |
Optimizing care in cultures with limited resources: choices and priorities
|
Ilbawi, A.
|
|
|
56 |
S1 |
p. S16
|
artikel
|
| 144 |
Our experience with COVID-19 infection in oncology patients
|
Djurmez, O.
|
|
|
56 |
S1 |
p. S89
|
artikel
|
| 145 |
PARP inhibitors in treatment of early stage breast cancer
|
Tutt, A.
|
|
|
56 |
S1 |
p. S11
|
artikel
|
| 146 |
Pathological complete response in early stage HER-2 positive breast cancer patients, receiving neoadjuvant chemotherapy/ Trastuzumab, in a single breast unit in Johannesburg
|
Bellomo, A.
|
|
|
56 |
S1 |
p. S53-S54
|
artikel
|
| 147 |
Pathology after neoadjuvant treatment – how to assess residual disease
|
Viale, G.
|
|
|
56 |
S1 |
p. S13
|
artikel
|
| 148 |
Patients’ quality of life and side effect perceptions in monarchE, a study of abemaciclib plus endocrine therapy in adjuvant treatment of HR+, HER2-, node-positive, high-risk, early breast cancer
|
Tolaney, S.
|
|
|
56 |
S1 |
p. S20-S21
|
artikel
|
| 149 |
Phase II neoadjuvant trial of Albumin-Bound Paclitaxel, Trastuzumab and Pertuzumab followed by anthracycline based regimens in patients with operable Her2 positive breast cancer (OMC-BC05)
|
Iwamoto, M.
|
|
|
56 |
S1 |
p. S52
|
artikel
|
| 150 |
Physician survey in the treatment of HR+/HER2 − metastatic breast cancer in Egypt
|
Aboelkheir, E.
|
|
|
56 |
S1 |
p. S31
|
artikel
|
| 151 |
Polymorphisms in antioxidant genes as predictive factors of radiotherapy late skin adverse events in breast cancer patients
|
Marinko, T.
|
|
|
56 |
S1 |
p. S63-S64
|
artikel
|
| 152 |
Post neoadjuvant HER2 treatment: real world data from a multicentric cohort
|
Luz, P.
|
|
|
56 |
S1 |
p. S22
|
artikel
|
| 153 |
Predicting clinical behaviour of breast phyllodes tumors: utility of Singapore nomogram
|
Gurawalia, J.
|
|
|
56 |
S1 |
p. S64
|
artikel
|
| 154 |
Predicting pathological complete response in the axilla post neoadjuvant chemotherapy in carcinoma breast
|
AbduRahman, A.
|
|
|
56 |
S1 |
p. S55
|
artikel
|
| 155 |
Predictive mathematical modelling of recurrence periods for the secondary distant metastases in patients with ER/PR/HER2/Ki-67 subtypes of breast cancer
|
Tyuryumina, E.
|
|
|
56 |
S1 |
p. S60-S61
|
artikel
|
| 156 |
Pre-pectoral breast reconstruction and complete implant coverage with a new bovine acellular pericardium matrix: Breast Center Villa Tiberia Hospital experience
|
Varvaras, D.
|
|
|
56 |
S1 |
p. S77-S78
|
artikel
|
| 157 |
Prescribing practices of endocrine therapy for premenopausal breast cancer patients in Mexico
|
Villarreal-Garza, C.
|
|
|
56 |
S1 |
p. S19-S20
|
artikel
|
| 158 |
Quality of life among young breast cancer patients
|
Sha, A.
|
|
|
56 |
S1 |
p. S39-S40
|
artikel
|
| 159 |
Quality of life in breast cancer patients – evidence from South India
|
Katpattil, S.
|
|
|
56 |
S1 |
p. S39
|
artikel
|
| 160 |
Radiation dose distribution in cardiac valves in left-sided breast cancer radiotherapy
|
Naimi, Z.
|
|
|
56 |
S1 |
p. S47-S48
|
artikel
|
| 161 |
Radiological evaluation of surgical margins after lumpectomy: comparison between mammography and ultrasound
|
Gentile, S.
|
|
|
56 |
S1 |
p. S75
|
artikel
|
| 162 |
Radiotherapy of ductal carcinoma in situ after conservative surgery: what is the role of the boost?
|
Ben Amor, R.
|
|
|
56 |
S1 |
p. S44-S45
|
artikel
|
| 163 |
RANK-c expression in ER-negative breast cancer cells alters sensitivity to tyrosine kinase inhibitors
|
Sirinian, C.
|
|
|
56 |
S1 |
p. S26-S27
|
artikel
|
| 164 |
Real-world study on HR+, HER2−, node-positive, high-risk early breast cancer (EBC) in France: patient profiles, management and treatment patterns
|
Pivot, X.
|
|
|
56 |
S1 |
p. S37-S38
|
artikel
|
| 165 |
Relationship between altered myoepithelial phenotype and the inflammatory cell infiltrate in progression of DCIS
|
Ohaida, K.
|
|
|
56 |
S1 |
p. S34
|
artikel
|
| 166 |
Reproductive outcomes in young breast cancer survivors treated (15–39) in Ontario, Canada: a population-based study
|
Rushton, M.
|
|
|
56 |
S1 |
p. S79
|
artikel
|
| 167 |
Residual disease after a neoadjuvant therapy: a strong prognostic and potentially predictive biomarker to personalize therapy
|
Krop, I.
|
|
|
56 |
S1 |
p. S13-S14
|
artikel
|
| 168 |
Results of darbepoetin alfa treatment of anaemia in chemotherapy-receiving early breast cancer patients - one-centre retrospective observational study
|
Jagiello-Gruszfeld, A.
|
|
|
56 |
S1 |
p. S58
|
artikel
|
| 169 |
Retrospective evaluation of immediate postmastectomy breast reconstruction with Tiloop BRA. Our experience with 103 patients
|
Pesotsky, R.
|
|
|
56 |
S1 |
p. S69-S70
|
artikel
|
| 170 |
Retrospective multicenter analysis comparing conventional with oncoplastic breast conservation: oncologic and surgical outcome in women with high risk breast cancer from the OPBC-01/iTOP2 study
|
Fitzal, F.
|
|
|
56 |
S1 |
p. S71-S72
|
artikel
|
| 171 |
Reverse abdominoplasty flap in reconstruction of anterior chest wall defects post extensive mastectomies
|
Sallam, I.
|
|
|
56 |
S1 |
p. S74
|
artikel
|
| 172 |
Risk adapted regional node Irradiation
|
Poortmans, P.
|
|
|
56 |
S1 |
p. S7-S8
|
artikel
|
| 173 |
Role of hypofractionated tumor bed boost in the era of short course radiotherapy in early stage breast cancer
|
Pandey, A.
|
|
|
56 |
S1 |
p. S45
|
artikel
|
| 174 |
Role of SPECT/CT in detection of the marked metastatic lymph node and the sentinel node, after neoadjuvant chemotherapy in patients with breast cancer
|
Dilege, E.
|
|
|
56 |
S1 |
p. S78
|
artikel
|
| 175 |
Role of time factor between External Beam Radiotherapy alone versus External Beam in combination with brachytherapy boost in breast cancer patients after breast conserving surgery
|
Pandey, A.
|
|
|
56 |
S1 |
p. S45-S46
|
artikel
|
| 176 |
Safety outcomes from monarchE: Phase 3 study of abemaciclib combined with endocrine therapy for the adjuvant treatment of HR+, HER-2-, node-positive, high risk, early breast cancer
|
Rugo, H.
|
|
|
56 |
S1 |
p. S23-S24
|
artikel
|
| 177 |
Savi scout radar versus wire-guided localisation in breast cancer surgery: a systematic review and meta-anaylsis of surgical outcomes
|
Latif, A.
|
|
|
56 |
S1 |
p. S74
|
artikel
|
| 178 |
Scenarios of cost-savings associated with Oncotype DX® test-guided decisions for adjuvant chemotherapy in early breast cancer in Germany
|
Lux, M.P.
|
|
|
56 |
S1 |
p. S33-S34
|
artikel
|
| 179 |
Should we delineate coronary arteries in right-sided breast cancer radiotherapy?
|
Naimi, Z.
|
|
|
56 |
S1 |
p. S47
|
artikel
|
| 180 |
Single-cell transcriptome sequencing analysis reveals gynaecomastia to breast cancer transition
|
Sun, H.
|
|
|
56 |
S1 |
p. S26
|
artikel
|
| 181 |
Single nucleotide polymorphisms rs17335780 and rs11979255 of the epidermal growth factor receptor (EGFR) correlate with tumor size in breast cancer
|
Sobočan, M.
|
|
|
56 |
S1 |
p. S25-S26
|
artikel
|
| 182 |
Standards in breast conservation and oncoplastic surgery
|
Fitzal, F.
|
|
|
56 |
S1 |
p. S8
|
artikel
|
| 183 |
State of the art in DCIS: who needs surgery, radiotherapy, endocrine therapy
|
Chua, B.H.
|
|
|
56 |
S1 |
p. S9
|
artikel
|
| 184 |
Strategies for breast cancer surgery during & after COVID-19 pandemic
|
Ashoor, A.
|
|
|
56 |
S1 |
p. S59
|
artikel
|
| 185 |
Surgery and prophylactic surgery in hereditary breast cancer
|
Morrow, M.
|
|
|
56 |
S1 |
p. S10-S11
|
artikel
|
| 186 |
Surgical and oncologic outcomes of robotic and conventional nipple-sparing mastectomy with immediate reconstruction: pooled analysis of individual patient-level data from international multi-centers
|
Park, H.S.
|
|
|
56 |
S1 |
p. S73-S74
|
artikel
|
| 187 |
Surveillance and follow-up
|
Partridge, A.
|
|
|
56 |
S1 |
p. S12
|
artikel
|
| 188 |
Survival after breast conservation versus mastectomy adjusted for comorbidity and socioeconomic status: national 6-year follow-up on 48986 women
|
de Boniface, J.
|
|
|
56 |
S1 |
p. S69
|
artikel
|
| 189 |
Survival comparison of HER2 breast cancer patients according to HR status: analysis of a single Portuguese centre
|
Nogueira-Costa, G.
|
|
|
56 |
S1 |
p. S62-S63
|
artikel
|
| 190 |
The assessment of primary breast cancer tumor size by magnetic resonance imaging, breast ultrasonography and mammography: a comparative study across intrinsic tumor subtype
|
Pop, C.F.
|
|
|
56 |
S1 |
p. S71
|
artikel
|
| 191 |
The contribution of radiation therapy to personalised care of patients with early breast cancer
|
Poortmans, P.
|
|
|
56 |
S1 |
p. S1
|
artikel
|
| 192 |
The difference between patient’s and population’s preferences for early staged breast cancer radiation therapy, focus on EBRT vs. IORT treatment options - qualitative research method
|
Stoimenov, V.
|
|
|
56 |
S1 |
p. S44
|
artikel
|
| 193 |
The effect of primary surgery in patients with stage IV breast cancer with bone metastasis only (protocol bomet MF14-01); a multi-center, registry study
|
Soran, A.
|
|
|
56 |
S1 |
p. S68
|
artikel
|
| 194 |
The effects of prognostic factors on metastasis and survival of patients with breast cancer using a multi-state model
|
Babaee, E.
|
|
|
56 |
S1 |
p. S60
|
artikel
|
| 195 |
The efficacy and safety of dual HER2 blockade with a pertuzumab-based regimen for metastatic breast cancer patients previously exposed to an anti-HER2 agent: a systematic review and meta-analysis
|
Chen, S.
|
|
|
56 |
S1 |
p. S41
|
artikel
|
| 196 |
The efficacy and safety of Tyrosine kinase inhibitors in HER-2 positive breast cancer with brain metastases: a systematic review and meta analysis
|
Yu, Y.
|
|
|
56 |
S1 |
p. S41
|
artikel
|
| 197 |
The evaluation of tumor-infiltrating lymphocytes (TILs) in early breast cancer: differences between histologic subtypes in a Portuguese cohort
|
Luz, P.
|
|
|
56 |
S1 |
p. S63
|
artikel
|
| 198 |
The level of adherence to medical standarts as a progrostic factor for breast cancer recurrence
|
Mitova, V.
|
|
|
56 |
S1 |
p. S65
|
artikel
|
| 199 |
The long term outcome of patients on primary endocrine therapy
|
Williams, L.
|
|
|
56 |
S1 |
p. S71
|
artikel
|
| 200 |
The Oncotype DX ® assay use in breast cancer in an Australian institutional setting
|
Choi, J.D.W.
|
|
|
56 |
S1 |
p. S66-S67
|
artikel
|
| 201 |
The role of genomic studies in breast cancer: the reality of a Portuguese hospital
|
Lima, A.
|
|
|
56 |
S1 |
p. S22
|
artikel
|
| 202 |
The role of tumor-infiltrating lymphocytes, prognostic and predictive signification in breast cancer
|
Tseluiko, A.
|
|
|
56 |
S1 |
p. S65
|
artikel
|
| 203 |
The secondary use and linking of health administrative and clinical trial data in cancer: attitudes towards data reuse in Australia
|
Hutchings, E.
|
|
|
56 |
S1 |
p. S84
|
artikel
|
| 204 |
The significance of skin edema in advanced breast cancer and its response to neoadjuvant chemotherapy
|
Laroiya, I.
|
|
|
56 |
S1 |
p. S41
|
artikel
|
| 205 |
TIL’s in triple-positive breast cancer
|
Urezkova, M.
|
|
|
56 |
S1 |
p. S28-S29
|
artikel
|
| 206 |
Title Page
|
|
|
|
56 |
S1 |
p. i
|
artikel
|
| 207 |
Tolerability of luteinising hormone releasing hormoneanalogue (LHRH) therapy in patients with early breast cancer treatedat the Institute for Oncology and Radiology of Serbia (IORS)
|
Dimitrijevic, M.
|
|
|
56 |
S1 |
p. S89
|
artikel
|
| 208 |
Tolerance and outcome of hypofractionated whole breast irradiation in young women: from controversies to evidence
|
Bohli, M.
|
|
|
56 |
S1 |
p. S22-S23
|
artikel
|
| 209 |
Totality of evidence for ABP 980, a trastuzumab biosimilar: results of chemo-synergy studies in combination with pertuzumab
|
Kolberg, H.-C.
|
|
|
56 |
S1 |
p. S83
|
artikel
|
| 210 |
Treatment strategy for locally advanced breast cancer in our department
|
Komatsu, H.
|
|
|
56 |
S1 |
p. S43
|
artikel
|
| 211 |
(Trial in progress) A real-life prospective, observational, post-authorisation safety study in adult breast cancer patients treated with neratinib in extended adjuvant in Europe: the NERLYFE study
|
Valenti, R.
|
|
|
56 |
S1 |
p. S20
|
artikel
|
| 212 |
Tumor angiogenesis: miRNAome abnormalities deregulate expression of angiogenic genes in breast cancer cells and contribute to increased formation of new but imperfect blood vessels
|
Halytskiy, V.
|
|
|
56 |
S1 |
p. S30
|
artikel
|
| 213 |
Tumor biology not stage dictates treatment choice: an analysis of NAPBC accreditation data from South Africa
|
Benn, C.A.
|
|
|
56 |
S1 |
p. S57
|
artikel
|
| 214 |
Tumor infiltrating lymphocytes (TILs) as prognostic biomarker in patients with breast cancer
|
Denkert, C.
|
|
|
56 |
S1 |
p. S5
|
artikel
|
| 215 |
Two-phased strategy for improvement of breast cancer care in Bangladesh
|
Sarker, M.
|
|
|
56 |
S1 |
p. S58
|
artikel
|
| 216 |
Type/timing of reconstruction when post-mastectomy radiotherapy is planned
|
Pusic, A.
|
|
|
56 |
S1 |
p. S9
|
artikel
|
| 217 |
Ultrasound-guided cryoablation as substitute for surgery in elderly patients with non resected breast cancer: pilot study with medium-term outcomes
|
Oliver-Goldaracena, J.M.
|
|
|
56 |
S1 |
p. S87-S88
|
artikel
|
| 218 |
Understanding the role of specialist follow up in early breast cancer, a retrospective review
|
Siow, Z.R.
|
|
|
56 |
S1 |
p. S89-S90
|
artikel
|
| 219 |
Unmet challenges in systemic therapy for early stage breast cancer
|
Burstein, H.J.
|
|
|
56 |
S1 |
p. S2
|
artikel
|
| 220 |
Upregulation of SLC26A9 resulted in the development and progression of HER2-positive breast cancer via activating PI3 K/ AKT signaling pathway
|
Ma, Z.
|
|
|
56 |
S1 |
p. S26
|
artikel
|
| 221 |
Use of indocyanine green (ICG) in detection of axillary sentinel lymph nodes for breast cancer
|
Nikolaou, C.
|
|
|
56 |
S1 |
p. S77
|
artikel
|
| 222 |
Validation of liquid biopsy for ESR1-mutation analysis in hormone-sensitive breast cancer: a pooled meta-analysis
|
Najim, O.
|
|
|
56 |
S1 |
p. S35
|
artikel
|
| 223 |
Video-endoscopic single-port breast surgery: personal experience
|
Roveda, L.
|
|
|
56 |
S1 |
p. S76
|
artikel
|
| 224 |
What patients want: Tradeoffs, preferences and thresholds
|
Spanic, T.
|
|
|
56 |
S1 |
p. S2
|
artikel
|
| 225 |
Why does endocrine therapy work and why does it stop working
|
André, F.
|
|
|
56 |
S1 |
p. S5
|
artikel
|
| 226 |
Would clipping and removal of all ultrasound abnormal metastatic lymph nodes predict nodal response in breast cancer patients with neoadjuvant chemotherapy?
|
Lim, G.H.
|
|
|
56 |
S1 |
p. S75
|
artikel
|
| 227 |
5-year follow-up of the safety, tolerability and efficacy of subcutaneous trastuzumab for the adjuvant treatment of HER2-positive early breast cancer. Results from the SafeHER Phase III trial
|
Gligorov, J.
|
|
|
56 |
S1 |
p. S21-S22
|
artikel
|
| 228 |
5-yr DMFS outcomes on the pre-operative use of MammaPrint and BluePrint for neoadjuvant decisions in the NBREaST II trial
|
Göker, E.
|
|
|
56 |
S1 |
p. S53
|
artikel
|
Tijdschrift beschrijving